Tg Therapeutics (TGTX) Non Operating Income (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Non Operating Income of -$14.4 million for Q1 2026, down 357.58% year-over-year from $5.6 million in Q1 2025, and down 167.21% quarter-over-quarter from -$5.4 million in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Non Operating Income (2011 - 2026) Analysis & Trends
Tg Therapeutics' Non Operating Income history runs 16 years deep, the most recent figure standing at -$14.4 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 357.58% year-over-year to -$14.4 million; the TTM figure through Mar 2026 stood at -$27.2 million (down 50.5% YoY), while the FY2025 annual figure was -$15.9 million, up 2.45% from the prior year.
- Non Operating Income for Q1 2026 stood at -$14.4 million, down from -$5.4 million in the prior quarter.
- The five-year high for Non Operating Income was -$854000.0 in Q3 2023, with the low at -$14.4 million in Q1 2026.
- The 5-year median for Non Operating Income is -$2.3 million (2024), against an average of -$3.5 million.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income plunged 856.21% in 2024, then surged 57.68% in 2025.
- Tg Therapeutics' Non Operating Income stood at -$932000.0 in 2022, then tumbled by 65.34% to -$1.5 million in 2023, then sank by 191.76% to -$4.5 million in 2024, then declined by 20.13% to -$5.4 million in 2025, then slumped by 167.21% to -$14.4 million in 2026.
- Business Quant data shows TGTX's Non Operating Income at -$14.4 million in Q1 2026, -$5.4 million in Q4 2025, and -$3.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Tg Therapeutics | 7.93 Bn | 7.25 Bn | 199.14 Mn | -11.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.44 Mn |
| Mar 31, 2026 | -14.43 Mn |
| Dec 31, 2025 | -5.40 Mn |
| Sep 30, 2025 | -3.46 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -4.50 Mn |
| Sep 30, 2024 | -8.17 Mn |
| Jun 30, 2024 | -2.27 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Sep 30, 2023 | -854,000.00 |
| Jun 30, 2023 | -2.94 Mn |
| Mar 31, 2023 | -2.24 Mn |
| Dec 31, 2022 | -932,000.00 |
| Sep 30, 2022 | -855,000.00 |
| Jun 30, 2022 | -1.57 Mn |
| Mar 31, 2022 | -2.14 Mn |
| Dec 31, 2021 | -391,000.00 |
| Sep 30, 2021 | -509,000.00 |